Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;79(2):307-310.
doi: 10.1053/j.ajkd.2021.10.002. Epub 2021 Nov 7.

Seroresponse to SARS-CoV-2 Vaccines Among Maintenance Dialysis Patients

Caroline M Hsu  1 , Daniel E Weiner  2 , Gideon N Aweh  3 , Harold J Manley  3 , Vladimir Ladik  3 , Jill Frament  3 , Dana Miskulin  2 , Christos Argyropoulos  4 , Kenneth Abreo  5 , Andrew Chin  6 , Reginald Gladish  7 , Loay Salman  8 , Doug Johnson  3 , Eduardo K Lacson  9
Affiliations

Seroresponse to SARS-CoV-2 Vaccines Among Maintenance Dialysis Patients

Caroline M Hsu et al. Am J Kidney Dis. 2022 Feb.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Multivariable regression of clinical characteristics associated with SARS-CoV-2 vaccine response. Response defined as SAb-IgG titer ≥1 U/L measured 14-74 days after vaccine series completion. The association for number of comorbidities is expressed per additional comorbidity. Peritoneal dialysis is compared to hemodialysis (either in-center or home). Analysis was performed with multivariable log Poisson regression with robust variances. See Table 1 notes for abbreviations and definitions.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Broseta J.J., Rodríguez-Espinosa D., Rodríguez N., et al. Humoral and cellular responses to mRNA-1273 and BNT162b2 SARS-CoV-2 vaccines administered to hemodialysis patients. Am J Kidney Dis. 2021;78(4):571–581. - PMC - PubMed
    1. Agur T., Ben-Dor N., Goldman S., et al. Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients - a prospective cohort study. Nephrol Dial Transplant. 2021;36(7):1347–1349. - PMC - PubMed
    1. Longlune N., Nogier M.B., Miedougé M., et al. High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients. Nephrol Dial Transplant. 2021;36(9):1704–1709. - PMC - PubMed
    1. Bensouna I., Caudwell V., Kubab S., et al. SARS-CoV-2 antibody response after a third dose of the BNT162b2 vaccine in patients receiving maintenance hemodialysis or peritoneal dialysis. Am J Kidney Dis. 2022;79(2):185–192. - PMC - PubMed
    1. Chan L., Fuca N., Zeldis E., Campbell K.N., Shaikh A. Antibody response to mRNA-1273 SARS-CoV-2 Vaccine in hemodialysis patients with and without prior COVID-19. CJASN. 2021;16(8):1258–1260. - PMC - PubMed

Publication types

Substances